Using proprietary technology that enables real-time GPS tracking, LiveOnNY, a nonprofit, federally recognised organ procurement organisation, and MediGO, a digital healthcare supply chain technology company, announced that they are collaborating to track organs as they travel across the nation. In…
Moderna, Inc., a biotechnology company that invented messenger RNA (mRNA) therapeutics and vaccines, and Generation Bio Co., a biotechnology company developing genetic medicines for people with common and rare diseases, recently announced that they have formed a strategic partnership to…
Tofersen, an investigational antisense drug for the treatment of people with superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis, was discussed at the Peripheral and Central Nervous System Drugs Advisory Committee meeting by the US Food and Drug Administration (FDA), according…
When concerns about drug resistance arise, Indian healthcare practitioners and pharmaceutical corporations step up their efforts to control the spread of tuberculosis through early identification and research for new medications. TB poses a serious risk to public health, with an…
Interested and eligible candidates may attend Walk-In-Interview (between 09:30 am to 11:30 am) for following posts on contract through third party. Candidates are required to carry Bio-Data, Recent Passport Size Photograph, Original documents of PAN Card, Aadhar Card, Experience Certificates,…
In reference to the letter of Mission Director, NHM & Executive Director, WBSH&FW Samiti, vide memo no. HFW/NUHM-454/2019/716(2) dated 15/02/2023, DH&FWS and Office of the CMOLL, Purba Bardhaman is inviting online Applications for engagement (on contractual basis) of Pharmacist for…
Walk-In-Interview for the following positions from In-House contractual employees of NHM working in the same post under the OSH&FW Society in other districts desiring to be posted in Puri District. The applications shall have the length of uninterrupted contractual service…
The Drugs Controller General of India (DCGI) will receive data from Eyestem for approval of a phase 2a first-in-human research for its product called Eyesight RPE for dry age-related macular degeneration (AMD). The approval will mark a key turning point…
The US Food and Drug Administration (FDA) has designated NTLA-2002 for the treatment of hereditary angioedema as a Regenerative Medicine Advanced Treatment (RMAT), according to Intellia Therapeutics, Inc., a leading clinical-stage genome editing business (HAE). NTLA-2002 is a CRISPR-based in…
An investigational new drug (IND) application for SNS-101, a conditionally active VISTA-blocking antibody, has been submitted to the US Food and Drug Administration (FDA) for a phase 1/2 clinical trial in patients with solid tumours, according to Sensei Biotherapeutics, Inc.,…
This will close in 0 seconds
